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Abstract
Circumcision is one of the oldest surgical procedures in the world. Despite 
its history, the medical benefits and risks of circumcision remain contro-
versial. Although neonatal circumcision reduces the development and 
recurrence rates of urinary tract infection (UTI) in children, routine cir-
cumcision is only recommended in children with high risk of UTI. Further 
large-scale studies are required to prove if topical steroid hormones are 
an alternative therapy to circumcision in the prevention of pediatric UTI. 
In men, it is well-established that circumcision can reduce the risks of 
transmitting sexually transmitted diseases (STDs), including human immu-
nodeficiency virus (HIV), human papilloma virus, type 2 herpes simplex 
virus, and syphilis. The World Health Organization and the United Nations 
Program on HIV/AIDS has recommended promotion of circumcision in areas 
with a high prevalence of heterosexually transmitted HIV. Since circumci-
sion only partially prevents STD, opponents worry that risk compensation 
(not using a condom and increased sexual partners) may overwhelmingly 
reduce the protective effects of circumcision. Parents and patients need 
to weigh the benefits and risks of male circumcision to make well-informed 
decisions about this procedure. [Tzu Chi Med J 2009;21(3):185–189]
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1. Introduction
Since circumcision may be performed for religious, 
social, and medical reasons, its prevalence varies 
widely among different ethnicities and cultures. The 
reported neonatal circumcision rate is 65.3% in the 
United States [1], but less than 2% in Scandinavian 
countries [2]. In Taiwan, the prevalence of neonatal 
circumcision is low, ranging from 0% to 1.4% [3]. 
As boys get older, the prevalence of circumcision in-
creases, from 7.2% at age 7, to 8.7% at age 13 [3].
Despite the long history of circumcision, the medical 
benefits and risks remain debatable. Herein, we review 
recent meta-analyses and clinical trials of the role of 
phimosis in pediatric urinary tract infection (UTI), and 
adult sexually transmitted disease (STD). The complica-
tions of circumcision are summarized. Finally, a brief 
review of circumcision and sexual function is provided.
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2. Circumcision and pediatric UTI
UTI is one of the most commonly observed bacterial 
infections leading to hospitalization in children. UTIs 
may reoccur in up to 30% of children; this can result 
in renal scarring, leading to hypertension [4]. Before the 
age of 1 year, boys are more susceptible to UTI than 
girls [5]. The trends of susceptibility in sex reverse 
after that time. Phimosis is thought to be one of major 
factors leading to UTI in boys. Hiraoka et al [5] evalu-
ated boys with febrile UTIs and found that the meatus 
of boys aged 0–6 months among their study subjects 
was significantly more tightly covered than that in 
healthy neonates. In Israel [6], boys receive neonatal 
circumcision routinely at 1 week. The incidence of UTI 
in Israeli boys peaks 2–4 weeks post-circumcision 
and then decreases later. As such, the incidence of 
UTI in Israeli boys is lower than girls after the age of 
8 weeks. In boys with acute pyelonephritis under the 
age of 6 months, a non-retractile prepuce was the 
most important risk factor for recurrent UTI [7]. In 
conclusion, phimosis plays an important role in both 
the development and recurrence of UTI in boys.
A recent systemic review and meta-analysis [8] eval-
uated the relationships between neonatal circumci-
sion and UTI in boys and concluded that neonatal 
circumcision may only be beneficial in boys at high 
risk of UTI. Although circumcision may reduce 90% 
of UTI in boys, a total of over 195 circumcision pro-
cedures are needed to prevent one hospital admission 
due to UTI. Since 1–2% of boys experienced UTI in 
the first 10 years of life, which is equal to the 2% 
complication rate from circumcision, the benefits of 
circumcision did not outweigh the risks. However, this 
research has been criticized because the authors 
may have overestimated the complication rate of ne-
onatal circumcision, and ignored the potential role of 
neonatal circumcision in the prevention of STD when 
the children became adults [9]. In addition, the cost 
of neonatal circumcision is much lower than that 
performed in childhood and adults.
An alternative therapy to circumcision is topical 
application of steroids for non-retractile prepuce [10]. 
In children with UTI, topical steroid treatment reduced 
the recurrence rate of UTI from 29.7% to 7.1% [11]. 
However, only a small group of patients was enrolled 
in that study and further studies are needed to con-
firm these findings. Topical steroids may not be able 
to replace the role of circumcision in the reduction 
of STD transmission in men.
3. Circumcision and STD
3.1. Circumcision and ulcerative STD
A number of observational studies have revealed a sig-
nificantly lower risk of ulcerative STD in circumcised 
men [12]. A recent meta-analysis by Weiss et al [12] 
showed that male circumcision may reduce the risk of 
syphilis and chancroid infection. The reduced risk 
of herpes simplex virus type 2 (HSV2) infection was 
of borderline statistical significance. Male circumci-
sion provided a 33% reduction in the risk of syphilis 
(relative risk [RR], 0.67; 95% confidence interval 
[CI], 0.54–0.83), and a 12% reduction in the risk of 
HSV2 (RR, 0.88; 95% CI, 0.77–1.01). Protective effects 
against chancroid were noted in six of seven studies 
(individual study RRs, 0.12–1.11). In 2009, a large 
scale (n = 5534), prospective, randomized study was 
performed in Uganda evaluating circumcision of ado-
lescents and men in the prevention of HSV2, human 
papilloma virus (HPV) and syphilis. They found that 
circumcision provided a 28% reduction in risk of 
HSV2 (RR, 0.72; 95% CI, 0.56–0.92; p = 0.008), with 
no significant protective role for syphilis (RR, 1.10; 
95% CI, 0.75–1.65; p = 0.44) [13].
3.2. Circumcision and non-ulcerative STD
Non-ulcerative STD, including Neisseria gonorrhoeae, 
Chlamydia trachomatis, and Trichomonas vaginalis, 
pose a threat to public health due to high prevalence 
and possible serious complications [14,15]. Previous 
observational studies have revealed conflicting rela-
tionships between non-ulcerative STD and circumci-
sion [16–21]. Recently, two large-scale prospective 
randomized studies evaluated the relationships be-
tween adult male circumcision and non-ulcerative 
STD, and revealed no protective effects of circumci-
sion. One study performed in South Africa revealed 
that the risk ratios for male circumcision against 
N. gonorrhoeae, C. trachomatis and T. vaginalis were 
0.97 (p = 0.84), 0.58 (p = 0.065) and 0.54 (p = 0.062), 
respectively [22]. The protective effect against T. 
vaginalis became statistically significant (RR, 0.49; 
p = 0.03) only in the as-treated analysis. The results 
from a study in Kenya revealed no protective effects 
of male circumcision on non-ulcerative STD [18]. 
From multivariate analysis, significant risk factors for 
non-ulcerative STD were multiple sex partners within 
< 30 days, and sexual intercourse during menses in 
the previous 6 months. The results confirmed that 
condom use was the only protective factor while not 
circumcised. In summary, circumcision yielded no 
or weak protective effects on non-ulcerative STD.
3.3. Circumcision and HPV infection
HPV infection is related to genital warts, penile cancer 
in men, and warts and cancer of the cervix, vulva, 
and vagina in women [23]. The prevalence of high-
risk HPV has been estimated to account for 99.7% of 
cervical cancer [24]. An observational study found 
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that circumcised men had lower prevalence rates of 
HPV than uncircumcised men (19.6% vs. 5.5%) [25]. 
Furthermore, partners of circumcised men had lower 
rates of cervical cancer than partners of uncircum-
cised men (odds ratio, 0.42; 95% CI, 0.23–0.79). A 
meta-analysis of observational studies confirmed 
that male circumcision is associated with a statisti-
cally significantly reduced risk of penile HPV and 
related lesions (RR, 0.56; 95% CI, 0.39–0.82) [26]. 
Two large-scale prospective randomized interven-
tional studies have been published recently [27,28]. 
One was performed at Orange Farm in South Africa 
with 1260 men randomized to the circumcision or 
control group [27]. In the 1-year follow-up, 14.8% of 
circumcised men and 22.3% of uncircumcised men 
had HPV infections. In total, circumcision reduced 
HPV infection by 34% (RR, 0.66; 95% CI, 0.51–0.86). 
Another study enrolled 3393 human immunodefi-
ciency virus (HIV)-negative, HSV2-negative, uncircum-
cised men (age range, 15–49 years) randomized to 
receive immediate or delayed circumcision at 24 
months. They found that circumcision provided a 35% 
reduction in the risk of HPV infection (0.65; 95% CI, 
0.46–0.90) with the prevalence of high-risk HPV gen-
otypes being 18.0% in the intervention group and 
27.9% in the control group [28].
3.4. Circumcision and HIV infection
The protective role of circumcision against HIV infec-
tion was first proposed in 1986 [29]. Since then, a 
large number of observational studies have revealed 
these protective effects [30,31]. From 2002 to 2006, 
three large-scale, prospective randomized controlled 
trials were conducted in South Africa [32], Uganda 
[33], and Kenya [34]. They evaluated the protective 
effects of circumcision against HIV in adult males. 
Based on the findings in these three trials [32–34], a 
recent Cochrane review concluded that medical male 
circumcision significantly reduces the acquisition of 
HIV in heterosexual men by between 38% and 66% 
over 24 months [35]. The reported complication rates 
were low and circumcision was reported to be quite 
safe. Inclusion of male circumcision into current HIV 
prevention policy and guidelines is suggested but 
further research on cost-effectiveness and feasibility 
is warranted [35]. A study by Williams et al published 
in 2006 hypothesized that male circumcision could 
prevent 2.0 million new HIV infections and 300,000 
deaths over the next 10 years in Sub-Saharan Africa 
[36]. However, there are criticisms that the study ignored 
the fact that the circumcision has only partial protec-
tive effects and risk compensation may eventually 
hamper the protective effects. The major limitations 
of circumcision in the prevention of STD is risk com-
pensation, i.e. men who have undergone circumci-
sion then increase risky behavior, such as not using 
condoms and increasing the number of sexual part-
ners [37]. In the South African trial [32], circumcised 
men reported higher numbers of sexual acts. The 
study in Kenya [34] did not report significant changes 
in behavior.
Since circumcision did not provide a completely 
protective effect against STD, circumcised men who 
increase risky behavior may eventually have an equal 
or higher rate of STD infection. In addition, HIV-infected 
circumcised men did not have a lower transmission 
rate of HIV to their sex partners, and risk compensa-
tion may increase the infection rate of partners [37].
3.5. Rationale for prevention of STD
There are several theories that explain why circumci-
sion may prevent men from contracting STD [30]. 
The first is that coverage of the prepuce provides a 
warm, moist area that makes replication of virus and 
bacteria easier. The second theory is that uncircum-
cised men easily sustain micro-abrasions on the skin 
during intercourse which gives an access to infec-
tion. Another plausible explanation is that the inner 
surface of the prepuce is abundant in CD4+ cells, 
macrophages, and dendritic cells (the target cells of 
HIV) without the protection of a keratinized surface. 
After removal of the inner surface during circumci-
sion, the susceptibility of hosts to HIV may decrease. 
Both ulcerative and non-ulcerative STDs have been 
shown to facilitate the transmission of HIV in numer-
ous studies [38]. Circumcision protects the hosts from 
ulcerative STD infection which may cause small 
wounds on the penis, and thus provides additional 
protective effects. According to a study by Fleming and 
Wasserheit, other STDs were associated with a two- 
to five-fold increase in HIV transmission rate in coun-
tries with different circumcision rates [39]. Although 
the exact role of these HIV cofactors is still unknown 
[40], it has been hypothesized that HSV2 and syphilis 
may enhance HIV acquisition by causing small lesions 
over the mucosa that permit HIV entry while simulta-
neously recruiting HIV-susceptible cells to the mucosa 
[41]. The mechanisms responsible for the synergistic 
association of HSV2 and syphilis have recently been 
further elucidated—demonstrating that both syphilitic 
and HSV2-infected tissue have increased numbers of 
CCR5-expressing T cells, theoretically increasing HIV 
susceptibility in active ulcerative STD [40].
3.6. Complications of circumcision
Generally, circumcision is a safe procedure with a 
reported complication rate ranging from 0.2% to 
0.3% [42]. The rate of complication decreases as the 
surgeon’s experience increases. In a study performed 
in Uganda in which 3011 men were circumcised, 
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the mean operative time required to complete sur-
gery was approximately 40 minutes for the first 100 
procedures, declining to 25 minutes for the subse-
quent 100 circumcisions [43]. The rate of moderate 
and severe adverse events was 8.8% (10/114) for the 
first 19 unsupervised procedures after training, 4.0% 
for the next 20–99 (13/328) and 2.0% for the last 
100 (p = 0.003) [43]. The reported complications in-
cluded death, bleeding, suture sinus tracts, infection, 
phimosis and concealed penis, adhesions, meatitis, 
meatal stenosis, chordee, urethrocutaneous fistula, 
amputations, and hypospadias [42].
3.7. Sexual function and circumcision
The function of the prepuce in human sexual response 
continues to be debated. A significant number of cir-
cumcised men experienced worsened erectile func-
tion and decreased penile sensitivity with improved 
satisfaction because of curing of underlying phimosis 
and balanoposthitis [44]. However, in two studies per-
formed in Africa, adult male circumcision was not as-
sociated with sexual dysfunction [45,46]. Circumcised 
men reported increased penile sensitivity and en-
hanced ease of reaching orgasm. Regarding the sat-
isfaction of female partners, O’Hara and O’Hara [44] 
surveyed women who had experience of sex with both 
circumcised and uncircumcised partners. A significant 
number of women reported greater likelihood of expe-
riencing vaginal orgasm, less discomfort, and greater 
intimacy with an uncircumcised partner. However, an-
other large prospective study [47] in South Africa re-
cently showed that only 2.9% of women reported less 
sexual satisfaction after their partners were circum-
cised. The overwhelming majority of women (97.1%) 
report either no change or improved sexual satisfac-
tion after their male partner was circumcised.
4. Conclusions
Circumcision lowers the rate of pediatric UTI and 
adult STD. Since circumcision is not without compli-
cation and does not completely avoid the risk of STD, 
routine circumcision is not recommended for infants 
and adults. Circumcision for medical reasons is sug-
gested in children with repeated balanoposthitis and 
a high risk of UTI, and in adults living in areas with a 
high prevalence of STD.
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